Epoprostenol (Prostacyclin) and Pulmonary Hypertension

This publication has 18 references indexed in Scilit:

• Arthritis & Rheumatism
  Published by Wiley ,2014
• Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease
  Annals of Internal Medicine, 2000
• Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial
  Annals of Internal Medicine, 2000
• Vasodilator Therapy for Primary Pulmonary Hypertension in Children
  Circulation, 1999
• Treatment of Severe Pulmonary Hypertension Secondary to Connective Tissue Diseases With Continuous IV Epoprostenol (Prostacyclin)
  Chest, 1998
• Massive Pulmonary Edema and Death After Prostacyclin Infusion in a Patient With Pulmonary Veno-occlusive Disease
  Chest, 1998
• A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension
  New England Journal of Medicine, 1996
• Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension.
  Heart, 1993
• High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
  Circulation, 1987
• LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
  The Lancet, 1984